These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

791 related items for PubMed ID: 10900099

  • 1. Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: clinical experience with histopathologic observations.
    Demirci H, McCormick SA, Finger PT.
    Arch Ophthalmol; 2000 Jul; 118(7):885-91. PubMed ID: 10900099
    [Abstract] [Full Text] [Related]

  • 2. Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: 12 years' experience.
    Kurli M, Finger PT.
    Graefes Arch Clin Exp Ophthalmol; 2005 Nov; 243(11):1108-14. PubMed ID: 15940485
    [Abstract] [Full Text] [Related]

  • 3. Topical mitomycin C chemotherapy for conjunctival melanoma and PAM with atypia.
    Finger PT, Czechonska G, Liarikos S.
    Br J Ophthalmol; 1998 May; 82(5):476-9. PubMed ID: 9713051
    [Abstract] [Full Text] [Related]

  • 4. [Mitomycin C in treatment of conjunctival melanoma and primary acquired melanosis].
    Werschnik C, Lommatzsch PK.
    Klin Monbl Augenheilkd; 1998 Jun; 212(6):465-8. PubMed ID: 9715467
    [Abstract] [Full Text] [Related]

  • 5. Cytologic changes in the conjunctiva mimicking malignancy after topical mitomycin C chemotherapy.
    Salomão DR, Mathers WD, Sutphin JE, Cuevas K, Folberg R.
    Ophthalmology; 1999 Sep; 106(9):1756-60; discussion 1761. PubMed ID: 10485547
    [Abstract] [Full Text] [Related]

  • 6. Topical interferon alfa in the treatment of conjunctival melanoma and primary acquired melanosis complex.
    Finger PT, Sedeek RW, Chin KJ.
    Am J Ophthalmol; 2008 Jan; 145(1):124-129. PubMed ID: 17981257
    [Abstract] [Full Text] [Related]

  • 7. [Conjunctival primary acquired melanosis].
    Krohn J, Monge OR.
    Tidsskr Nor Laegeforen; 2005 Sep 22; 125(18):2480-2. PubMed ID: 16186865
    [Abstract] [Full Text] [Related]

  • 8. [Management of conjunctival malignant melanoma associated with primary acquired melanosis (PAM) using 0.02% mitomycin C eyedrops].
    Groh MJ, Holbach LM, Kühnel B, Conway RM, Naumann GO.
    Ophthalmologe; 2003 Sep 22; 100(9):708-12. PubMed ID: 14504895
    [Abstract] [Full Text] [Related]

  • 9. Role of topical chemotherapy for primary acquired melanosis and malignant melanoma of the conjunctiva and cornea: review of the evidence and recommendations for treatment.
    Chalasani R, Giblin M, Conway RM.
    Clin Exp Ophthalmol; 2006 Sep 22; 34(7):708-14. PubMed ID: 16970772
    [Abstract] [Full Text] [Related]

  • 10. [The treatment of a primary acquired melanosis of the conjunctiva with atypia by low dose of Mitomycin C 0.02 % - case report with follow up of 2 years].
    Schmidt M, Maier M, Schmidt T, Klaehsen D, Merté RL.
    Klin Monbl Augenheilkd; 2001 Dec 22; 218(12):805-9. PubMed ID: 11805873
    [Abstract] [Full Text] [Related]

  • 11. Outcomes in 15 patients with conjunctival melanoma treated with adjuvant topical mitomycin C: complications and recurrences.
    Ditta LC, Shildkrot Y, Wilson MW.
    Ophthalmology; 2011 Sep 22; 118(9):1754-9. PubMed ID: 21652078
    [Abstract] [Full Text] [Related]

  • 12. The treatment of primary acquired melanosis (PAM) with atypia by topical Mitomycin C.
    Pe'er J, Frucht-Pery J.
    Am J Ophthalmol; 2005 Feb 22; 139(2):229-34. PubMed ID: 15733981
    [Abstract] [Full Text] [Related]

  • 13. Use of mitomycin C in the treatment of conjunctival primary acquired melanosis with atypia.
    Frucht-Pery J, Pe'er J.
    Arch Ophthalmol; 1996 Oct 22; 114(10):1261-4. PubMed ID: 8859090
    [Abstract] [Full Text] [Related]

  • 14. Topical mitomycin treatment for primary acquired melanosis of the conjunctiva.
    Yuen VH, Jordan DR, Brownstein S, Dorey MW.
    Ophthalmic Plast Reconstr Surg; 2003 Mar 22; 19(2):149-51. PubMed ID: 12644763
    [Abstract] [Full Text] [Related]

  • 15. Conjunctival melanoma arising from diffuse primary acquired melanosis in a young black woman.
    Colby KA, Nagel DS.
    Cornea; 2005 Apr 22; 24(3):352-5. PubMed ID: 15778614
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of a short-term topical interferon α-2b treatment for histologically proven melanoma and primary acquired melanosis with atypia.
    Garip A, Schaumberger MM, Wolf A, Herold TR, Miller CV, Klingenstein A, Schebitz-Walter K, Hintschich CR.
    Orbit; 2016 Apr 22; 35(1):29-34. PubMed ID: 26636727
    [Abstract] [Full Text] [Related]

  • 17. Conjunctival melanoma arising from primary acquired melanosis in a patient with neurofibromatosis type I.
    Stacy RC, Kenyon KR, Jakobiec FA, Colby KA.
    Cornea; 2010 Feb 22; 29(2):232-4. PubMed ID: 20023582
    [Abstract] [Full Text] [Related]

  • 18. Postoperative topical mitomycin C in conjunctival squamous cell neoplasia.
    Akpek EK, Ertoy D, Kalayci D, Hasiripi H.
    Cornea; 1999 Jan 22; 18(1):59-62. PubMed ID: 9894938
    [Abstract] [Full Text] [Related]

  • 19. Intumescent cataract after topical mitomycin-C for conjunctival malignant melanoma.
    Sacu S, Ségur-Eltz N, Horvat R, Lukas JR, Zehetmayer M.
    Am J Ophthalmol; 2003 Aug 22; 136(2):375-7. PubMed ID: 12888073
    [Abstract] [Full Text] [Related]

  • 20. Limbal stem cell deficiency after topical mitomycin C therapy for primary acquired melanosis with atypia.
    Lichtinger A, Pe'er J, Frucht-Pery J, Solomon A.
    Ophthalmology; 2010 Mar 22; 117(3):431-7. PubMed ID: 20060167
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.